NHI Q2 diluted EPS $0.79 vs $0.81; NAREIT FFO guidance cut, normalized FFO guidance raised
National Health Investors reported second-quarter 2025 results with diluted EPS of $0.79, down from $0.81 a year earlier, while normalized FFO per diluted share rose to $1.22 from $1.18. The company lowered its 2025 NAREIT FFO per diluted share guidance to $4.46-$4.50 from $4.64-$4.70 but raised its normalized FFO and normalized FAD guidance, and it expects an $8.8 million reduction in third-quarter rental income tied to the Discovery lease termination.
Key points
- Diluted EPS was $0.79 versus $0.81 in the prior-year quarter, including $1.3 million of proxy contest expenses.
- Normalized FFO per diluted share was $1.22 versus $1.18; NAREIT FFO per diluted share was $1.19 versus $1.18.
- 2025 NAREIT FFO per diluted share guidance was lowered to $4.46-$4.50 from $4.64-$4.70; normalized FFO guidance was raised to $4.78-$4.82 from $4.68-$4.73.
- Discovery Senior Living lease was terminated effective August 1, 2025, with an expected $8.8 million third-quarter rental income reduction.
The filing
Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.